Results 81 to 90 of about 93,175 (205)

Wearable Electronic Monitoring of Vital Signs in Hospitalised Adults: A Nursing Focused Scoping Review of Clinical, Economic and Implementation Outcomes

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aim To synthesise evidence on wearable devices for continuous vital signs monitoring in adult hospital inpatients, focusing on clinical effectiveness, nursing perspectives, workflow impact, patient experience and resource implications. Design Scoping review.
Sian Myfanwy Shaw, Sophie Bethan Shaw, Gillian Janes   +2 more
wiley   +1 more source

EBOLA

Zdravniški Vestnik, 2014
The ongoing outbreak of Ebola virus disease is by far the largest in  the history of Ebola virus since its initial description in 1976. Apart from dramatic increase of detected cases in the current outbreak of Ebola virus disease in West Africa, there ...
Tadeja Kotar
doaj  

Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Ebola virus disease

EFSA Journal, 2017
Ebola virus disease has been assessed according to the criteria of the Animal Health Law (AHL), in particular criteria of Article 7 on disease profile and impacts, Article 5 on the eligibility of Ebola virus disease to be listed, Article 9 for the ...
EFSA Panel on Animal Health and Welfare (AHAW), Simon More, Anette Bøtner, Andrew Butterworth, Paolo Calistri, Klaus Depner, Sandra Edwards, Bruno Garin‐Bastuji, Margaret Good, Christian Gortázar Schmidt, Virginie Michel, Miguel Angel Miranda, Søren Saxmose Nielsen, Mohan Raj, Liisa Sihvonen, Hans Spoolder, Jan Arend Stegeman, Hans‐Hermann Thulke, Antonio Velarde, Preben Willeberg, Christoph Winckler, Francesca Baldinelli, Alessandro Broglia, Beatriz Beltrán Beck, Lisa Kohnle, Joana Morgado, Dominique Bicout   +26 more
doaj   +1 more source

What do we really fear? The epidemiological characteristics of Ebola and our preparedness [PDF]

Epidemiology and Health, 2014
Ebola virus disease (hereafter Ebola) has a high fatality rate; currently lacks a treatment or vaccine with proven safety and efficacy, and thus many people fear this infection.
Moran Ki
doaj   +1 more source

Ebola Virus Diseases

African Journal of Clinical and Experimental Microbiology, 2014
Since the first reported outbreak of Ebola in 1976, there have been approximately 25 outbreaks all of which, except two, have been reported only in east and central Africa. The current outbreak and a single case reported in 1994 in Ivory Coast are the only two outbreaks in West Africa (7).
Elisha, A, Adegboro, B
openaire   +3 more sources

A multiplex assay to detect mosquito species, bloodmeal host source and Plasmodium in malaria vectors using Nanopore amplicon sequencing

Medical and Veterinary Entomology, EarlyView.
Insectary‐reared mosquitoes were simultaneously assessed for species identification, bloodmeal source analysis and Plasmodium detection, using a single multiplexed sequencing run on the MinION sequencing platform. The method was applied to 150 insectary‐reared mosquitoes, representing nine species blood‐fed with five vertebrate hosts and 40 samples for
E. Abby Rogers, Dieunel Derilus, Christopher Sandi, Lisa Reimer, Audrey Lenhart, Lucy Mackenzie Impoinvil   +5 more
wiley   +1 more source

Rapid Decision Algorithm for Patient Triage during Ebola Outbreaks

Emerging Infectious Diseases
The low specificity of Ebola virus disease clinical signs increases the risk for nosocomial transmission to patients and healthcare workers during outbreaks.
Denis-Luc Ardiet, Justus Nsio, Gaston Komanda, Rebecca M. Coulborn, Emmanuel Grellety, Francesco Grandesso, Richard Kitenge, Dolla L. Ngwanga, Bibiche Matady, Guyguy Manangama, Mathias Mossoko, John K. Ngwama, Placide Mbala, Francisco Luquero, Klaudia Porten, Steve Ahuka-Mundeke   +15 more
doaj   +1 more source

Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro

Molecular Therapy: Nucleic Acids, 2019
Ebola virus is the causative agent of Ebola virus disease, a severe, often fatal illness in humans. So far, there are no US Food and Drug Administration (FDA)-approved therapeutics directed against Ebola virus.
Anne Sadewasser, Erik Dietzel, Sven Michel, Michael Klüver, Markus Helfer, Tamara Thelemann, Richard Klar, Markus Eickmann, Stephan Becker, Frank Jaschinski   +9 more
doaj   +1 more source

Did Ebola emerge in West Africa by a policy-driven phase change in agroecology? Ebola's social context [PDF]

, 2014
SCOPUS: no.jinfo:eu-repo/semantics ...
Balan R, Carrere R, Claudia Pittiglio, Cooke F, Evans R, Fairhead J, Ferrand P, Fouladbash L, Hogerwerf L, Madelaine C, Marius Gilbert, Moran L S, Murombedzi J, Okubo A, Raffaele Mattioli, Richard Kock, Robert G Wallace, Rodrick Wallace, Shafie N J, Watts S, Wise T A, World Bank, Zagema B   +22 more
core   +1 more source

Virus-encoded miRNAs in Ebola virus disease [PDF]

Scientific Reports, 2018
AbstractEbola virus (EBOV) is a negative-strand RNA virus that replicates in the cytoplasm and causes an often-fatal hemorrhagic fever. EBOV, like other viruses, can reportedly encode its own microRNAs (miRNAs) to subvert host immune defenses. miRNAs are short noncoding RNAs that can regulate gene expression by hybridizing to multiple mRNAs, and viral ...
Janice Duy, Anna N. Honko, Louis A. Altamura, Sandra L. Bixler, Suzanne Wollen-Roberts, Nadia Wauquier, Aileen O’Hearn, Eric M. Mucker, Joshua C. Johnson, Joshua D. Shamblin, Justine Zelko, Miriam A. Botto, James Bangura, Moinya Coomber, M. Louise Pitt, Jean-Paul Gonzalez, Randal J. Schoepp, Arthur J. Goff, Timothy D. Minogue   +18 more
openaire   +3 more sources